Pricing Log in Create free account

Ardelyx, Inc. (ARDX) vs Attovia Therapeutics, Inc. (ATTO)

Ardelyx, Inc. and Attovia Therapeutics, Inc. are both Biotechnology companies. Ardelyx, Inc. and Attovia Therapeutics, Inc. are of similar size ($786.8M and $764.8M). Across the 4 metrics below, Attovia Therapeutics, Inc. leads on 4 and Ardelyx, Inc. on 0.

Valuation

Metric ARDX ATTO Biotechnology median
P/E n/m — 11.58
P/S 1.68 n/m 9.61
P/B 4.79 n/m 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 1.66 n/m 9.43
Earnings yield (7.10%) — (32.28%)
Free cash flow yield (2.03%) 0.00% (22.27%)

Profitability

Metric ARDX ATTO Biotechnology median
Gross margin 94.46% — 68.81%
Operating margin (7.71%) — 0.00%
Net margin (11.85%) — 0.00%
Free cash flow margin (3.41%) — 0.00%
Return on equity (34.85%) — (50.30%)
Return on assets (10.33%) — (45.47%)
Return on invested capital (17.21%) 0.00% 0.00%

Growth

Metric ARDX ATTO Biotechnology median
Revenue growth (TTM) 17.57% — 6.78%
EPS growth (last fiscal year) (52.94%) — 29.88%
Revenue growth, 5-year CAGR 121.90% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ARDX ATTO Biotechnology median
Debt to equity 1.54 0.00 0.00
Current ratio 3.45 9.39 4.74
Net debt to EBITDA 1.63 — 1.01

Dividend

Metric ARDX ATTO Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ARDX ATTO Biotechnology median
Market cap 786.79m 764.77m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack